Haleon (NYSE:HLN) Cut to Hold at Jefferies Financial Group

Jefferies Financial Group cut shares of Haleon (NYSE:HLN) from a buy rating to a hold rating in a report released on Wednesday, MarketBeat Ratings reports.

Other equities analysts have also recently issued research reports about the company. Berenberg Bank restated a “buy” rating on shares of Haleon in a report on Wednesday, August 5th. Deutsche Bank Aktiengesellschaft raised Haleon from a “sell” rating to a “hold” rating in a report on Friday, October 30th. Weiss Ratings reissued a “hold (c)” rating on shares of Haleon in a research report on Friday, September 25th. Zacks Research cut Haleon from a “hold” rating to a “strong sell” rating in a report on Thursday, October 22nd. Finally, Wall Street Zen cut Haleon from a “buy” rating to a “hold” rating in a research report on Saturday, October 3rd. Two equities research analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Haleon presently has a consensus rating of “Moderate Buy” and an average target price of $4.90.

Haleon Stock Performance

Shares of HLN stock opened at $9.12 on Wednesday. The business’s 50 day moving average is $9.43 and its two-hundred day moving average is $9.75. The company has a market capitalization of $40.19 billion, a P/E ratio of 23.40, a P/E/G ratio of 2.05 and a beta of 0.15. The company has a current ratio of 0.69, a quick ratio of 0.52 and a debt-to-equity ratio of 0.38. Haleon has a 12-month low of $8.38 and a 12-month high of $11.28.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Parkside Financial Bank & Trust boosted its position in shares of Haleon by 20.4% during the 2nd quarter. Parkside Financial Bank & Trust now owns 6,233 shares of the company’s stock worth $58,000 after purchasing an additional 1,055 shares in the last quarter. Personal CFO Solutions LLC raised its position in Haleon by 11.5% in the 1st quarter. Personal CFO Solutions LLC now owns 15,673 shares of the company’s stock worth $157,000 after purchasing an additional 1,620 shares during the last quarter. Sterling Capital Management LLC lifted its stake in Haleon by 1.9% in the 3rd quarter. Sterling Capital Management LLC now owns 88,039 shares of the company’s stock valued at $792,000 after acquiring an additional 1,624 shares in the last quarter. Ethic Inc. raised its stake in Haleon by 1.5% in the 3rd quarter. Ethic Inc. now owns 111,428 shares of the company’s stock worth $1,003,000 after purchasing an additional 1,658 shares in the last quarter. Finally, Diversify Advisory Services LLC grew its stake in shares of Haleon by 7.7% in the third quarter. Diversify Advisory Services LLC now owns 24,023 shares of the company’s stock worth $239,000 after purchasing an additional 1,711 shares during the last quarter. 6.67% of the stock is currently owned by institutional investors and hedge funds.

Haleon Company Profile

Haleon plc is a global consumer healthcare company that develops and sells nonprescription health products. Its portfolio spans oral health, pain relief, vitamins and supplements, respiratory health, digestive health, and therapeutic skin care.

Its brands include Sensodyne, parodontax and Polident in oral care; Advil, Panadol and Voltaren for pain relief; and Centrum, Emergen-C and Theraflu in supplements and respiratory care. Haleon sells its products in markets around the world.

Haleon became an independent public company in 2022 after separating from GSK.